Learn more about SEND from CDISC
Create SEND database with sendigR
FDA Guidance - Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers
ICH - GUIDANCE ON NONCLINICAL SAFETY STUDIES FOR THE CONDUCT OF HUMAN CLINICAL TRIALS AND MARKETING AUTHORIZATION FOR PHARMACEUTICAL M3(R2)
FDA - M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
Making sense of SEND; the Standard for Exchange of Nonclinical Data
The Standard for the Exchange of Nonclinical Data (SEND): Challenges and Promises
Leveraging the Value of CDISC SEND Data Sets for Cross-Study Analysis: Incidence of Microscopic Findings in Control Animals
SEND harmonization & cross-study analysis: A proposal to better harvest the value from SEND data